CN108508196A - 一种检测人调节性t细胞亚型的试剂盒及检测方法 - Google Patents
一种检测人调节性t细胞亚型的试剂盒及检测方法 Download PDFInfo
- Publication number
- CN108508196A CN108508196A CN201810331146.2A CN201810331146A CN108508196A CN 108508196 A CN108508196 A CN 108508196A CN 201810331146 A CN201810331146 A CN 201810331146A CN 108508196 A CN108508196 A CN 108508196A
- Authority
- CN
- China
- Prior art keywords
- cell
- antibody
- human
- incubated
- obtains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003289 regulatory T cell Anatomy 0.000 title claims abstract description 43
- 238000001514 detection method Methods 0.000 title claims abstract description 23
- 210000004027 cell Anatomy 0.000 claims abstract description 227
- 239000007788 liquid Substances 0.000 claims abstract description 61
- 210000004369 blood Anatomy 0.000 claims abstract description 39
- 239000008280 blood Substances 0.000 claims abstract description 38
- 210000005087 mononuclear cell Anatomy 0.000 claims abstract description 36
- 239000003550 marker Substances 0.000 claims abstract description 30
- 239000007853 buffer solution Substances 0.000 claims abstract description 29
- 239000006210 lotion Substances 0.000 claims abstract description 25
- 239000012528 membrane Substances 0.000 claims abstract description 25
- 238000005406 washing Methods 0.000 claims abstract description 25
- 238000010790 dilution Methods 0.000 claims abstract description 22
- 239000012895 dilution Substances 0.000 claims abstract description 22
- 238000004043 dyeing Methods 0.000 claims abstract description 19
- 230000003834 intracellular effect Effects 0.000 claims abstract description 18
- 239000002458 cell surface marker Substances 0.000 claims abstract description 15
- 230000004913 activation Effects 0.000 claims abstract description 13
- 239000012930 cell culture fluid Substances 0.000 claims abstract description 13
- 239000000975 dye Substances 0.000 claims abstract description 13
- 239000002981 blocking agent Substances 0.000 claims abstract description 12
- 210000004698 lymphocyte Anatomy 0.000 claims abstract description 12
- 239000002158 endotoxin Substances 0.000 claims abstract description 8
- 229920006008 lipopolysaccharide Polymers 0.000 claims abstract description 8
- 239000011534 wash buffer Substances 0.000 claims abstract description 5
- 230000014509 gene expression Effects 0.000 claims description 35
- 238000001556 precipitation Methods 0.000 claims description 35
- 239000006228 supernatant Substances 0.000 claims description 28
- 238000011534 incubation Methods 0.000 claims description 27
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 21
- 239000006285 cell suspension Substances 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 21
- ZMJPCIAEJKVKMQ-UHFFFAOYSA-M [4-[[4-[benzyl(methyl)amino]phenyl]-[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium;chloride Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)N(C)CC=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 ZMJPCIAEJKVKMQ-UHFFFAOYSA-M 0.000 claims description 19
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 15
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 14
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 13
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 13
- 102000003814 Interleukin-10 Human genes 0.000 claims description 13
- 108090000174 Interleukin-10 Proteins 0.000 claims description 13
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims description 13
- 238000001994 activation Methods 0.000 claims description 12
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 10
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 8
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 8
- 239000012894 fetal calf serum Substances 0.000 claims description 8
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 102100025074 C-C chemokine receptor-like 2 Human genes 0.000 claims description 6
- 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 claims description 6
- 108060003951 Immunoglobulin Proteins 0.000 claims description 6
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 6
- 102000018358 immunoglobulin Human genes 0.000 claims description 6
- 239000012114 Alexa Fluor 647 Substances 0.000 claims description 5
- 239000012103 Alexa Fluor 488 Substances 0.000 claims description 4
- 239000012110 Alexa Fluor 594 Substances 0.000 claims description 4
- 239000012117 Alexa Fluor 700 Substances 0.000 claims description 4
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 claims description 4
- 230000009977 dual effect Effects 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 4
- VYNDHICBIRRPFP-UHFFFAOYSA-N pacific blue Chemical compound FC1=C(O)C(F)=C2OC(=O)C(C(=O)O)=CC2=C1 VYNDHICBIRRPFP-UHFFFAOYSA-N 0.000 claims description 4
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 230000003196 chaotropic effect Effects 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 abstract description 3
- 238000010186 staining Methods 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 238000005119 centrifugation Methods 0.000 description 22
- 102000013691 Interleukin-17 Human genes 0.000 description 10
- 108050003558 Interleukin-17 Proteins 0.000 description 10
- 238000004140 cleaning Methods 0.000 description 8
- 230000002093 peripheral effect Effects 0.000 description 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 210000001744 T-lymphocyte Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000005259 peripheral blood Anatomy 0.000 description 5
- 239000011886 peripheral blood Substances 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 3
- KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 3
- 239000003710 calcium ionophore Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- CJAONIOAQZUHPN-KKLWWLSJSA-N ethyl 12-[[2-[(2r,3r)-3-[2-[(12-ethoxy-12-oxododecyl)-methylamino]-2-oxoethoxy]butan-2-yl]oxyacetyl]-methylamino]dodecanoate Chemical compound CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC CJAONIOAQZUHPN-KKLWWLSJSA-N 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- XOIQMTLWECTKJL-HXPDMXKUSA-M sodium;(3r,4s)-4-[(2s,5r,7s,8r,9s)-2-[(2r,5s)-5-ethyl-5-[(2r,3s,5r)-5-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate Chemical compound [Na+].C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)C(C)C([O-])=O)O2 XOIQMTLWECTKJL-HXPDMXKUSA-M 0.000 description 3
- 206010059484 Haemodilution Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000002602 induced regulatory T cell Anatomy 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 2
- PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 description 1
- 229960004359 iodixanol Drugs 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- MIKKOBKEXMRYFQ-WZTVWXICSA-N meglumine amidotrizoate Chemical compound C[NH2+]C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I MIKKOBKEXMRYFQ-WZTVWXICSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 210000002501 natural regulatory T cell Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4704—Inhibitors; Supressors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/495—Transforming growth factor [TGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5428—IL-10
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/7051—T-cell receptor (TcR)-CD3 complex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70517—CD8
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810331146.2A CN108508196B (zh) | 2018-04-13 | 2018-04-13 | 一种检测人调节性t细胞亚型的试剂盒及检测方法 |
US16/348,793 US20200378969A1 (en) | 2018-04-13 | 2018-06-13 | Kit for detecting subset of human regulatory t cell, and detection method thereof |
PCT/CN2018/091106 WO2019196194A1 (zh) | 2018-04-13 | 2018-06-13 | 一种检测人调节性t细胞亚型的试剂盒及检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810331146.2A CN108508196B (zh) | 2018-04-13 | 2018-04-13 | 一种检测人调节性t细胞亚型的试剂盒及检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108508196A true CN108508196A (zh) | 2018-09-07 |
CN108508196B CN108508196B (zh) | 2020-10-27 |
Family
ID=63381723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810331146.2A Active CN108508196B (zh) | 2018-04-13 | 2018-04-13 | 一种检测人调节性t细胞亚型的试剂盒及检测方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20200378969A1 (zh) |
CN (1) | CN108508196B (zh) |
WO (1) | WO2019196194A1 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109254148A (zh) * | 2018-10-12 | 2019-01-22 | 东莞暨南大学研究院 | 人体外周血t细胞免疫功能精简评估试剂盒及评估方法 |
CN109254147A (zh) * | 2018-10-12 | 2019-01-22 | 东莞暨南大学研究院 | 人体外周血免疫细胞功能全面评估试剂盒及评估方法 |
CN109270265A (zh) * | 2018-10-12 | 2019-01-25 | 东莞暨南大学研究院 | 人体外周血杀伤性免疫细胞功能评估试剂盒及评估方法 |
CN110608991A (zh) * | 2019-09-09 | 2019-12-24 | 浙江普罗亭健康科技有限公司 | 基于质谱流式检测技术的细胞周期检测试剂盒及检测方法 |
CN113419067A (zh) * | 2021-05-26 | 2021-09-21 | 广州医科大学 | 一种用于评估造血干细胞移植病人cmv感染后免疫状态的多肽组合物以及检测试剂盒 |
CN114609388A (zh) * | 2022-05-11 | 2022-06-10 | 广州华澳生物科技有限公司 | 微流控免疫检测方法及装置 |
EP3889603A4 (en) * | 2018-12-01 | 2022-08-10 | Mingdao Innovation (Beijing) Medical-Tech Co., Ltd. | METHOD FOR PREPARING A LYMPHOCYTE SAMPLE FOR FLOW CYTOMETRY ANALYSIS |
CN116699116A (zh) * | 2023-06-14 | 2023-09-05 | 河南省人民医院 | 检测嗜碱性粒细胞cd284表达水平的物质的应用 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113899893B (zh) * | 2021-09-30 | 2024-01-30 | 杭州联科生物技术股份有限公司 | 一种ivd流式产品的开发方法 |
CN114112567A (zh) * | 2021-10-29 | 2022-03-01 | 郑州金域临床检验中心有限公司 | 一种结核感染t细胞斑点试验样本的制备方法 |
CN114705518B (zh) * | 2021-12-31 | 2024-07-30 | 伊莱瑞特(武汉)生物技术有限公司 | 悬浮细胞孵育染色方法及免疫荧光检测方法 |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050079555A1 (en) * | 1998-09-22 | 2005-04-14 | Kerstin Willmann | Flow cytometric, whole blood dendritic cell immune function assay |
CN101883844A (zh) * | 2007-10-12 | 2010-11-10 | 分子医学马克斯德尔布吕克中心 | 快速分离人Foxp3+Treg细胞的方法和试剂盒 |
US20120088678A1 (en) * | 2010-09-08 | 2012-04-12 | Sanford-Burnham Medical Research Institute | Method for prediction of response to rheumatoid arthritis therapeutics |
CN102766597A (zh) * | 2012-07-31 | 2012-11-07 | 中国人民解放军第三军医大学 | 利用FOXP3为标记物分选Treg细胞的方法 |
CN103235135A (zh) * | 2013-04-26 | 2013-08-07 | 史其新 | 一种用于表征外周调节性t细胞抑制活性的特征细胞群的检测方法及其应用 |
US20130225427A1 (en) * | 2010-09-08 | 2013-08-29 | Sanford-Burnham Medical Research Institute | Method for prediction of response to immune mediated disease therapeutics |
CN103782173A (zh) * | 2011-07-01 | 2014-05-07 | 贝克曼考尔特公司 | 调节t细胞和识别、获得、以及用于治疗基于免疫的紊乱的方法 |
WO2015014871A1 (en) * | 2013-07-31 | 2015-02-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and kits for identifying effector treg cells |
CN104364656A (zh) * | 2012-07-02 | 2015-02-18 | 索蒂奥公司 | 诊断和监视癌症的体外方法 |
CN104651309A (zh) * | 2015-02-04 | 2015-05-27 | 中山大学孙逸仙纪念医院 | 人外周血CD4+CD25+Foxp3+调节性T细胞的分选扩增方法 |
CN106932576A (zh) * | 2017-03-22 | 2017-07-07 | 山东大学深圳研究院 | 一种人调节性t细胞的免疫抑制功能的检测方法 |
CN107314965A (zh) * | 2017-04-26 | 2017-11-03 | 马鞍山易廷生物科技有限公司 | 基于流式结合icp‑ms单细胞蛋白检测的样本前处理方法 |
CN107478563A (zh) * | 2017-07-19 | 2017-12-15 | 浙江省人民医院 | 一种基于流式细胞术检测结核特异性双细胞因子的方法 |
CN107603948A (zh) * | 2017-08-14 | 2018-01-19 | 武汉圣济科技有限公司 | 一种直接体外诱导人外周血单个核细胞成为复合型抗原非特异性调节性t细胞的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3368659A1 (en) * | 2015-10-28 | 2018-09-05 | Life Technologies AS | Selective expansion of different subpopulations of t cells by the alteration of cell surfacing signals and signal ratio |
-
2018
- 2018-04-13 CN CN201810331146.2A patent/CN108508196B/zh active Active
- 2018-06-13 WO PCT/CN2018/091106 patent/WO2019196194A1/zh active Application Filing
- 2018-06-13 US US16/348,793 patent/US20200378969A1/en active Pending
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050079555A1 (en) * | 1998-09-22 | 2005-04-14 | Kerstin Willmann | Flow cytometric, whole blood dendritic cell immune function assay |
CN101883844A (zh) * | 2007-10-12 | 2010-11-10 | 分子医学马克斯德尔布吕克中心 | 快速分离人Foxp3+Treg细胞的方法和试剂盒 |
US20120088678A1 (en) * | 2010-09-08 | 2012-04-12 | Sanford-Burnham Medical Research Institute | Method for prediction of response to rheumatoid arthritis therapeutics |
US20130225427A1 (en) * | 2010-09-08 | 2013-08-29 | Sanford-Burnham Medical Research Institute | Method for prediction of response to immune mediated disease therapeutics |
CN103782173A (zh) * | 2011-07-01 | 2014-05-07 | 贝克曼考尔特公司 | 调节t细胞和识别、获得、以及用于治疗基于免疫的紊乱的方法 |
CN104364656A (zh) * | 2012-07-02 | 2015-02-18 | 索蒂奥公司 | 诊断和监视癌症的体外方法 |
CN102766597A (zh) * | 2012-07-31 | 2012-11-07 | 中国人民解放军第三军医大学 | 利用FOXP3为标记物分选Treg细胞的方法 |
CN103235135A (zh) * | 2013-04-26 | 2013-08-07 | 史其新 | 一种用于表征外周调节性t细胞抑制活性的特征细胞群的检测方法及其应用 |
WO2015014871A1 (en) * | 2013-07-31 | 2015-02-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and kits for identifying effector treg cells |
CN104651309A (zh) * | 2015-02-04 | 2015-05-27 | 中山大学孙逸仙纪念医院 | 人外周血CD4+CD25+Foxp3+调节性T细胞的分选扩增方法 |
CN106932576A (zh) * | 2017-03-22 | 2017-07-07 | 山东大学深圳研究院 | 一种人调节性t细胞的免疫抑制功能的检测方法 |
CN107314965A (zh) * | 2017-04-26 | 2017-11-03 | 马鞍山易廷生物科技有限公司 | 基于流式结合icp‑ms单细胞蛋白检测的样本前处理方法 |
CN107478563A (zh) * | 2017-07-19 | 2017-12-15 | 浙江省人民医院 | 一种基于流式细胞术检测结核特异性双细胞因子的方法 |
CN107603948A (zh) * | 2017-08-14 | 2018-01-19 | 武汉圣济科技有限公司 | 一种直接体外诱导人外周血单个核细胞成为复合型抗原非特异性调节性t细胞的方法 |
Non-Patent Citations (14)
Title |
---|
BENEDIKT FRITZSCHING等: "Naive regulatory T cells a novel subpopulation defined by resistance toward CD95L-mediated cell death", 《BLOOD》 * |
KEVIN N. BROWN等: "Parallel Loss of Myeloid and Plasmacytoid Dendritic Cells from Blood and Lymphoid Tissue in Simian AIDS", 《J IMMUNOL》 * |
付小兵等: "《生物治疗中的转化医学》", 30 November 2014, 第四军医大学出版社 * |
吴俊英等: "《子宫内膜异位症诊疗新进展》", 31 March 2014, 华中科技大学出版社 * |
吴后男: "《流式细胞术原理与应用教程》", 29 February 2008, 北京大学医学出版社 * |
姜钰等: "多色流式细胞术检测CHB患者外周血多重细胞因子分泌的Th细胞亚群", 《中国肝脏病杂志(电子版)》 * |
宋洋子等: "十色流式检测HIV_AIDS患者外周血中T淋巴细胞亚群及活化状态", 《中华实验和临床感染病杂志(电子版)》 * |
张慧云等: "调节性T细胞在过敏性疾病发病机制中的作用", 《细胞与分子免疫学杂志》 * |
杨智清: "原发性肝细胞癌患者肿瘤浸润CD8+FoxP3+调节性T淋巴细胞的表达频率与表型分析", 《中国博士学位论文全文数据库 医药卫生科技辑》 * |
王建中: "《临床流式细胞分析》", 31 August 2005, 上海科学技术出版社 * |
王海灏等: "人天然型和诱导型CD4+CD25+FoxP3+CD127-Treg细胞表型多样性的比较", 《中国组织工程研究》 * |
詹能勇等: "结核多肽特异性细胞内因子多色流式分析", 《中国实验诊断学》 * |
贾连群等: "《现代基础医学理论与技术进展》", 31 August 2015, 中国医药科技出版社 * |
骆文智等: "《广东省医学会第五次计划生育学术会议暨孕前优生健康检查研讨会论文汇编》", 31 August 2012, 广东省医学会计划生育学分会、广东省人口计生委科技处编印 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109254148A (zh) * | 2018-10-12 | 2019-01-22 | 东莞暨南大学研究院 | 人体外周血t细胞免疫功能精简评估试剂盒及评估方法 |
CN109254147A (zh) * | 2018-10-12 | 2019-01-22 | 东莞暨南大学研究院 | 人体外周血免疫细胞功能全面评估试剂盒及评估方法 |
CN109270265A (zh) * | 2018-10-12 | 2019-01-25 | 东莞暨南大学研究院 | 人体外周血杀伤性免疫细胞功能评估试剂盒及评估方法 |
EP3889603A4 (en) * | 2018-12-01 | 2022-08-10 | Mingdao Innovation (Beijing) Medical-Tech Co., Ltd. | METHOD FOR PREPARING A LYMPHOCYTE SAMPLE FOR FLOW CYTOMETRY ANALYSIS |
CN110608991A (zh) * | 2019-09-09 | 2019-12-24 | 浙江普罗亭健康科技有限公司 | 基于质谱流式检测技术的细胞周期检测试剂盒及检测方法 |
CN110608991B (zh) * | 2019-09-09 | 2022-04-29 | 浙江普罗亭健康科技有限公司 | 基于质谱流式检测技术的细胞周期检测试剂盒及检测方法 |
CN113419067A (zh) * | 2021-05-26 | 2021-09-21 | 广州医科大学 | 一种用于评估造血干细胞移植病人cmv感染后免疫状态的多肽组合物以及检测试剂盒 |
CN114609388A (zh) * | 2022-05-11 | 2022-06-10 | 广州华澳生物科技有限公司 | 微流控免疫检测方法及装置 |
CN114609388B (zh) * | 2022-05-11 | 2022-07-19 | 广州华澳生物科技有限公司 | 微流控免疫检测方法及装置 |
CN116699116A (zh) * | 2023-06-14 | 2023-09-05 | 河南省人民医院 | 检测嗜碱性粒细胞cd284表达水平的物质的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN108508196B (zh) | 2020-10-27 |
WO2019196194A1 (zh) | 2019-10-17 |
US20200378969A1 (en) | 2020-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108508196A (zh) | 一种检测人调节性t细胞亚型的试剂盒及检测方法 | |
CROWE et al. | Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages | |
CN108795869A (zh) | 一种循环肿瘤细胞阳性富集方法 | |
CN106932576A (zh) | 一种人调节性t细胞的免疫抑制功能的检测方法 | |
Ball et al. | In vitro growth and multiplication of the malaria parasite, Plasmodium knowlesi | |
CN109254155A (zh) | 一种检测非洲猪瘟病毒抗原胶体金免疫层析试纸及制备方法和应用 | |
CN107299111A (zh) | 检测MOG‑IgG的CBA试剂盒用的细胞爬片组件制备、CBA检测试剂盒及其应用 | |
CN105259354B (zh) | 结核T细胞释放γ‑干扰素检测试剂盒及其使用方法 | |
Card | PPLO of human genital origin: serological classification of strains and antibody distribution in man | |
CN107064085A (zh) | 自然杀伤细胞活性测定方法 | |
Ferrebee et al. | Studies on Malarial Parasites: III. A Procedure for Preparing Concentrates of Plasmodium Vivax | |
Liebhaber et al. | Replication of rubella virus in a continuous line of African green monkey kidney cells (Vero). | |
CN103760345B (zh) | 一种利用外周血检测结核分枝杆菌感染的试剂盒及其应用 | |
James et al. | Isolation, characterization, and culture of intestinal intraepithelial lymphocytes | |
CN108546676A (zh) | 隧道磁场技术分离和富集外周血中稀有细胞的方法 | |
Swenson et al. | Comparison of two rapid culture methods for detection of cytomegalovirus in clinical specimens | |
EP1842068A1 (en) | Use of multiparametric flow cytometry for the diagnosis, prognosis, and validation of immunotherapies in autoimmune, hematologic, and lymphoproliferative diseases | |
CN109060640A (zh) | 用于检测b淋巴细胞的cd系列细胞检测玻片 | |
CN102317446A (zh) | 分离的单核细胞群及相关的治疗应用 | |
Rønneseth et al. | Flow cytometry assay for intracellular detection of Infectious Pancreatic Necrosis virus (IPNV) in Atlantic salmon (Salmo salar L.) leucocytes | |
Stirk et al. | Comparative sensitivity of three methods for the diagnosis of cytomegalovirus lung infection | |
Lewis et al. | T and B cell analogues from peripheral blood of immune channel catfish, Ictalurus punctatus | |
CN109294987A (zh) | 一种非治疗目的的恢复浸润性t淋巴细胞免疫功能的方法 | |
CN117783532A (zh) | 一种检测人血液滤泡t辅助细胞亚型的试剂盒及其应用 | |
CN103160465A (zh) | 一种用于细胞体外分离纯化的试剂盒及其应用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190104 Address after: 121001 Jinzhou City, Liaoning Province, Taihe District Lingnan Xili Jinxitiandi D District 35-97 Applicant after: He Shaoheng Address before: Room 101, 153-13 Innovation Road, Shenyang District, China (Liaoning) Free Trade Pilot Area, Shenyang, Liaoning Province Applicant before: SHENYANG HUIMINYUAN BIOTECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210401 Address after: 110027 no.36-3, Huahai Road, Shenyang Economic and Technological Development Zone, Liaoning Province Patentee after: SHENYANG HUIMINYUAN BIOTECHNOLOGY Co.,Ltd. Address before: 121001 Jinzhou City, Liaoning Province, Taihe District Lingnan Xili Jinxitiandi D District 35-97 Patentee before: He Shaoheng |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A reagent kit and detection method for detecting human regulatory T cell subtypes Effective date of registration: 20231225 Granted publication date: 20201027 Pledgee: Shenyang Science and Technology Venture Capital Co.,Ltd. Pledgor: SHENYANG HUIMINYUAN BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023210000355 |